When is MEDP's latest earnings report released?
The most recent financial report for Medpace holdings, inc. (MEDP) covers the period of 2025Q4 and was published on 2025/12/31. This report is prepared according to IFRS/US GAAP standards and includes key financial indicators—Revenue, Profitability, Cash Flow, and Capital Structure. This information is essential for investors evaluating MEDP's short-term business performance and financial health. For the latest updates on MEDP's earnings releases, visit this page regularly.
Where does MEDP fall in the P/E River chart?
According to historical valuation range analysis, Medpace holdings, inc. (MEDP)'s current price-to-earnings (P/E) ratio is 28.06, placing it in the Value zone on the P/E River chart. This level indicates that the market's expectations for future earnings are already reflected in the share price, with the valuation currently leaning conservative. Investors are advised to further examine the company's fundamentals and its position in the industry cycle to validate whether the valuation is justified.
What is the operating profit of MEDP?
According to the latest financial report, Medpace holdings, inc. (MEDP) reported an Operating Profit of 153.27M with an Operating Margin of 21.63% this period, representing a growth of 22.25% compared to the same period last year. Operating Profit reflects the company's core business efficiency and cost control, making it a key indicator for evaluating operational strength and profitability.
How is MEDP's revenue growth?
In the latest financial report, Medpace holdings, inc. (MEDP) announced revenue of 708.45M, with a Year-Over-Year growth rate of 32.03%. Revenue growth can be driven by product mix changes, market share expansion, price adjustments, or international market penetration. Investors should also monitor gross margin and regional revenue distribution for a comprehensive view of growth quality and sustainability.
How much cash does MEDP have?
At the end of the period, Medpace holdings, inc. (MEDP) held Total Cash and Cash Equivalents of 497.05M, accounting for 0.25 of total assets. Both current and quick ratios indicate robust short-term debt repayment ability. High cash reserves typically mean the company has strong liquidity, supporting operational needs, expansion investments, or shareholder returns.
Does MEDP go with three margins increasing?
In the latest report, Medpace holdings, inc. (MEDP) achieved the “three margins increasing” benchmark, with a gross margin of 29%%, operating margin of 21.63%%, and net margin of 19.1%%. This demonstrates improvement in profitability, which is a key signal for fundamental analysis. Investors should consider margin trends alongside other financial indicators to assess MEDP's profit trajectory and future growth potential.
Is MEDP's EPS continuing to grow?
According to the past four quarterly reports, Medpace holdings, inc. (MEDP)'s earnings per share (EPS) shows a steady growth trend, with the latest EPS at 4.76. If EPS continues to rise due to revenue growth and cost optimization, it can support P/E valuation recovery and attract long-term investors.
What is the FCF of MEDP?
Medpace holdings, inc. (MEDP)'s Free Cash Flow (FCF) for the period is 188.12M, calculated as Operating Cash Flow minus Capital Expenditures, representing a rise of 2.78% compared with the previous period. Positive FCF growth provides stable funding for dividends, debt repayment, or strategic acquisitions, and is an important measure of true profitability and shareholder return potential.
What are the PEG ratio and PE ratio of MEDP?
The latest valuation data shows Medpace holdings, inc. (MEDP) has a Price-To-Earnings (PE) ratio of 28.06 and a Price/Earnings-To-Growth (PEG) ratio of 1.4. A PEG below 1 usually suggests the market is underestimating growth potential, while a PEG above 1 indicates high growth expectations are already priced in. Investors should conduct a comprehensive valuation by considering historical growth, market forecasts, and industry cycles.
